UPDATE : Friday, May 29, 2020
Celltrion, Emory University to develop new drug for Atherosclerosis
Celltrion said Thursday that it has signed an “incubation” agreement with E...
by Lee Han-soo  |  2018-09-20 13:22
FDA approves Bifido’s strain as new dietary ingredient
Bifido, a local microbiome company, said Tuesday that the U.S. Food and Dru...
by Lee Han-soo  |  2018-09-18 17:14
Nature Cell shares spike despite investment alert warning
Industry watchers are looking for answers why shares of Nature Cell have be...
by Nam Doo-hyun  |  2018-09-14 16:08
GC Cell shares spike on winning FDA nod for Immuncell-LC
Stock prices of GC Cell and ToolGen went in the opposite direction on Wedne...
by Nam Doo-hyun  |  2018-09-12 16:05
‘Regulator’s scrutiny into ToolGen’s patent issue might discourage biotech research’
The biotech industry is paying close attention to how the recent controvers...
by So Jae-hyeon  |  2018-09-12 14:25
‘ToolGen’s KOSDAQ listing might be in peril’
ToolGen, a local biotech firm specialized in gene editing, has been mired i...
by Nam Doo-hyun  |  2018-09-10 14:59
‘Pharmaceutical stocks to bottom out soon’
Korean pharmaceutical and biotech shares are expected to have an upward tre...
by Nam Doo-hyun  |  2018-08-29 14:34
Celltrion completes P3 clinical trials for Remsima in Europe
Celltrion said it has completed phase 3 clinical trial for Remsima SC, the ...
by Lee Han-soo  |  2018-08-29 14:33
Merck to globally distribute T&R Biofab’s bio-ink
T&R Biofab said Wednesday that it has signed an original equipment manufact...
by Lee Han-soo  |  2018-08-22 12:30
Biotech firms grudge over regulator’s plan to toughen disclosure rules
Pharmaceutical and biotech industry officials are expressing discontent ove...
by So Jae-hyeon  |  2018-08-17 11:51
NIBEC claims stable growth despite loss in Q2
Nano Intelligence Biomedical Engineering Corp. (NIBEC) said Thursday that t...
by Lee Han-soo  |  2018-08-16 18:11
Medipost sales increases but profits fall in 1H
Medipost said Thursday that it recorded 22.6 billion won ($20 million) in s...
by Lee Han-soo  |  2018-08-16 11:25
Local patents increasingly target obesity
Amid forecasts that the obesity therapy market will rapidly grow, local res...
by Nam Doo-hyun  |  2018-08-14 16:26
Korean pharmaceuticals enter biobank business
Korean pharmaceutical companies are jumping into the biobank business. Biob...
by Marian Chu  |  2018-08-14 12:07
Who will be first to develop new acute pancreatitis remedy?
Korea’s Samsung Bioepis and Japan’s Takeda Pharmaceutical have teamed up to...
by Nam Doo-hyun  |  2018-08-14 10:32
Samsung Bioepis to begin clinical trials for severe acute pancreatitis treatment
Samsung Bioepis said Monday that it plans to begin a phase 1 clinical study...
by Lee Han-soo  |  2018-08-13 11:25
Celltrion to conduct clinical trials for its biosimilars
Celltrion said Friday that it has applied for the clinical trials for CT-P1...
by Lee Han-soo  |  2018-08-10 14:35
Bio stock slump drags down diagnostics, equipment, reagent companies
The shares of diagnostics, equipment, reagent and clinical agent companies ...
by Nam Doo-hyun  |  2018-08-09 14:29
FDA points out problems in Celltrion’s plant
The U.S. Food and Drug Administration (FDA) has issued an additional “Form ...
by Lee Han-soo  |  2018-08-08 14:42
Beijing Northland mass produces Viromed’s NL003 for P3 clinical trial
Viromed said Tuesday that Beijing Northland Biotech, its Chinese partner, h...
by Lee Han-soo  |  2018-08-07 15:39
Back to Top